|
GNPDA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.240200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.852000E-02 |
| Normal-vs-Stage2 |
2.537800E-02 |
| Normal-vs-Stage3 |
5.800700E-03 |
| Normal-vs-Stage4 |
2.872400E-02 |
| Stage1-vs-Stage2 |
6.949800E-01 |
| Stage1-vs-Stage3 |
3.671400E-01 |
| Stage1-vs-Stage4 |
7.440800E-01 |
| Stage2-vs-Stage3 |
7.190200E-01 |
| Stage2-vs-Stage4 |
9.828000E-01 |
| Stage3-vs-Stage4 |
6.849400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.598400E-03 |
| Normal-vs-AfricanAmerican |
2.875400E-01 |
| Normal-vs-Asian |
9.078000E-01 |
| Caucasian-vs-AfricanAmerican |
6.680600E-01 |
| Caucasian-vs-Asian |
2.213200E-01 |
| AfricanAmerican-vs-Asian |
6.045800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.060270E-03 |
| Normal-vs-Female |
2.514400E-01 |
| Male-vs-Female |
1.436020E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.178000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.565810E-02 |
| Normal-vs-Age(61-80Yrs) |
1.888280E-02 |
| Normal-vs-Age(81-100Yrs) |
1.794370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.481800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.296400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.098600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.765000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.624800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.157400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.915600E-01 |
| Normal-vs-Grade 2 |
3.440400E-03 |
| Normal-vs-Grade 3 |
3.625800E-02 |
| Normal-vs-Grade 4 |
3.713900E-02 |
| Grade 1-vs-Grade 2 |
5.147800E-01 |
| Grade 1-vs-Grade 3 |
6.403400E-01 |
| Grade 1-vs-Grade 4 |
5.569600E-01 |
| Grade 2-vs-Grade 3 |
2.359800E-01 |
| Grade 2-vs-Grade 4 |
7.975200E-01 |
| Grade 3-vs-Grade 4 |
5.647800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.746400E-02 |
| Normal-vs-ccB subtype |
8.040600E-03 |
| ccA subtype-vs-ccB subtype |
9.023900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.869520E-02 |
| Normal-vs-N1 |
4.366400E-01 |
| N0-vs-N1 |
7.221800E-01 |
|
|
